Dr. Catherine Elizabeth Makin, DO

Dr. Makin practices at Westlake Eye Specialists - New Braunfels in New Braunfels, Texas.

Dr. Makin's NPI, 1932469251, was assigned on May 21, 2012. Dr. Makin graduated from Touro University California - Vallejo in 2012. Dr. Makin holds Texas license S7491.

Dr. Makin's primary practice is Westlake Eye Specialists - New Braunfels, at 218 E Austin, New Braunfels, TX 78130. The practice phone is (830) 625-6905.

Dr. Makin's primary practice is Westlake Eye Specialists - New Braunfels in New Braunfels, Texas. Dmand AI also links Dr. Makin to 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Makin's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Makin practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Makin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Makin is board certified in ophthalmology by the AOA Board of Ophthalmology and Otolaryngology. Dr. Makin is licensed in Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Makin treats.

CMS data shows 3,795 Medicare services from Dr. Makin across 22 procedure codes in 2024, for 861 Medicare patients. Medicare paid $438,682 for them.

CMS counts 861 Medicare patients who saw Dr. Makin in 2024. The largest group is 65 to 74, with 409 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Makin's median patient age at 72, with 60% women.

In 2024, Dr. Makin wrote 1,564 Medicare Part D claims for 457 patients. 62% of them were for generic drugs. CMS names the drug for 1,478 of them, across 26 drugs with 11 or more claims each, at $277,774 in total drug cost. In 2023, CMS named 1,148 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Makin for performance year 2024, reported as part of a group. Dr. Makin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 300 procedures of cataract surgery by Dr. Makin, more than 89% of the clinicians it reports for that procedure.

CMS Open Payments shows 208 general payments to Dr. Makin from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. TissueTech, Inc. paid the most, $2,413.

Dmand AI lists 1 award for Dr. Makin, most recently Humanism in Medicine in 2009.

Dr. Makin graduated from Touro University California - Vallejo in 2012. Dr. Makin is a member of AAO, AOA and ASCRS.

Dr. Makin is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.